Results 111 to 120 of about 8,627 (176)

The clinical efficacy of dabigatran etexilate for preventing stroke in atrial fibrillation patients

, 2013
Christopher R Ellis, Daniel W KaiserVanderbilt Heart and Vascular Institute, Nashville, TN, USAAbstract: The use of novel oral anticoagulants (NOACs) for stroke and systemic embolism prevention in the setting of specifically non valvular atrial ...
Ellis CR, Kaiser DW
core  

Successful intravenous thrombolysis in acute ischemic stroke after reversal of dabigatran etexilate with idarucizumab at the end of therapeutic time window. [PDF]

Turk J Emerg Med, 2020
Vukorepa G, Deveđija S, Crnjaković M, Karakaš M, Ćuk Ž.   +4 more
europepmc   +1 more source

Extremely Elevated International Normalized Ratio in a Patient with Dabigatran Etexilate Use. [PDF]

Cureus, 2019
Memon W, Aamir M, Memon A.
europepmc   +1 more source

Bioequivalence of a Newly Developed Dabigatran Etexilate Tablet Versus the Commercial Capsule and Impact of Rabeprazole-Induced Elevated Gastric pH on Exposure in Healthy Subjects. [PDF]

Am J Cardiovasc Drugs, 2020
Harada A, Ikushima I, Haranaka M, Yanagihara A, Nakayama D.   +4 more
europepmc   +1 more source

Effects of Long-term Thrombin Inhibition (Dabigatran Etexilate) on Spontaneous Thrombolytic Activity during the Progression of Atherosclerosis in ApoE^-/--LDLR^-/- Double-Knockout Mice. [PDF]

Korean Circ J, 2020
Sanda T, Yoshimura M, Hyodo K, Ishii H, Yamashita T.   +4 more
europepmc   +1 more source

Assessing the relative contribution of CYP3A-and P-gp-mediated pathways to the overall disposition and drug-drug interaction of dabigatran etexilate using a comprehensive mechanistic physiological-based pharmacokinetic model. [PDF]

Front Pharmacol
Udomnilobol U, Dunkoksung W, Sakares W, Jianmongkol S, Prueksaritanont T.   +4 more
europepmc   +1 more source

Safety of dabigatran etexilate for the secondary prevention of venous thromboembolism in children.

Blood, 2020
Brandão LR, Albisetti M, Halton J, Bomgaars L, Chalmers E, Mitchell LG, Nurmeev I, Svirin P, Kuhn T, Zapletal O, Tartakovsky I, Simetzberger M, Huang F, Sun Z, Kreuzer J, Gropper S, Brueckmann M, Luciani M, DIVERSITY Study Investigators.   +18 more
europepmc   +1 more source

Preliminary Observations on the Antihypertension Action of Dabigatran Etexilate in Patients With Nonvalvular Atrial Fibrillation: A Prospective Multicenter Single-Arm Interventional Study. [PDF]

Cardiol Res, 2020
Yamamoto T, Urata H.
europepmc   +1 more source

Successful thrombolysis for acute ischaemic stroke after reversal of dabigatran etexilate with idarucizumab. [PDF]

BMJ Case Rep, 2019
Loh CH, Herkes G.
europepmc   +1 more source